Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?

doi:10.2174/1381612824666180130122450

Review

. 2018;24(9):960-973.

doi: 10.2174/1381612824666180130122450.

Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?

Sarah A Robertson¹, Hanan H Wahid¹, Peck Yin Chin¹, Mark R Hutchinson², Lachlan M Moldenhauer¹, Jeffrey A Keelan³

Affiliations

¹ Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide SA 5005, Australia.
² ARC Centre for Nanoscale Biophotonics and School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia.
³ Division of Obstetrics & Gynaecology, University of Western Australia, Perth WA 6008, Australia.

PMID: 29384054
DOI: 10.2174/1381612824666180130122450

Review

Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?

Sarah A Robertson et al. Curr Pharm Des. 2018.

. 2018;24(9):960-973.

doi: 10.2174/1381612824666180130122450.

Authors

Sarah A Robertson¹, Hanan H Wahid¹, Peck Yin Chin¹, Mark R Hutchinson², Lachlan M Moldenhauer¹, Jeffrey A Keelan³

Affiliations

¹ Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide SA 5005, Australia.
² ARC Centre for Nanoscale Biophotonics and School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia.
³ Division of Obstetrics & Gynaecology, University of Western Australia, Perth WA 6008, Australia.

PMID: 29384054
DOI: 10.2174/1381612824666180130122450

Abstract

Inflammatory activation, a major driver of preterm birth and subsequent neonatal morbidity, is an attractive pharmacological target for new preterm birth therapeutics. Inflammation elicited by intraamniotic infection is causally associated with preterm birth, particularly in infants delivered ≤34 weeks' gestation. However, sterile triggers of PTB, including placental ischaemic injury, uterine distention, cervical disease, or imbalance in the immune response, also act through inflammatory mediators released in response to tissue damage. Toll-like Receptors (TLRs) are critical upstream gate-keepers controlling the inflammatory activation that precedes preterm delivery, as well as in normal term labour. In particular, TLR4 is implicated for its capacity to sense and integrate a range of disparate infectious and sterile pro-inflammatory triggers, and so acts as a point-ofconvergence through which a range of infectious and sterile agents can activate and accelerate the parturition cascade. Recent studies point to the TLR4 signalling complex as a tractable target for the inhibition of fetal, placental & intraamniotic inflammatory cytokine production. Moreover, studies on mice show that novel small molecule antagonists of TLR4 signalling are highly effective in preventing preterm birth induced by bacterial mimetic LPS, heat-killed E. coli or the TLR4-dependent pro-inflammatory lipid, Platelet Activating Factor (PAF). In this review, we discuss the role of TLR4 in regulating the timing of birth and the potential utility of TLR4 antagonists as novel therapeutics for preterm delivery.

Keywords: Cytokines; inflammation; parturition; pregnancy; toll-like receptor 4..

Cited by 6 articles

MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice.
Gao J, Teng L, Yang S, Huang S, Li L, Zhou L, Liu G, Tang H. Gao J, et al. Biochem Pharmacol. 2021 Apr;186:114499. doi: 10.1016/j.bcp.2021.114499. Epub 2021 Mar 4. Biochem Pharmacol. 2021. PMID: 33675774 Free PMC article.
Maternal regulation of inflammatory cues is required for induction of preterm birth.
Cappelletti M, Doll JR, Stankiewicz TE, Lawson MJ, Sauer V, Wen B, Kalinichenko VV, Sun X, Tilburgs T, Divanovic S. Cappelletti M, et al. JCI Insight. 2020 Nov 19;5(22):e138812. doi: 10.1172/jci.insight.138812. JCI Insight. 2020. PMID: 33208552 Free PMC article.
Mesenchymal Stem Cells Attenuate Lipopolysaccharide-Induced Inflammatory Response in Human Uterine Smooth Muscle Cells.
Mani A, Hotra JW, Blackwell SC, Goetzl L, Refuerzo JS. Mani A, et al. AJP Rep. 2020 Jul;10(3):e335-e341. doi: 10.1055/s-0040-1715166. Epub 2020 Sep 23. AJP Rep. 2020. PMID: 33094025 Free PMC article.
Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in Mice.
Wahid HH, Chin PY, Sharkey DJ, Diener KR, Hutchinson MR, Rice KC, Moldenhauer LM, Robertson SA. Wahid HH, et al. Am J Pathol. 2020 May;190(5):1030-1045. doi: 10.1016/j.ajpath.2020.01.008. Epub 2020 Feb 18. Am J Pathol. 2020. PMID: 32084361 Free PMC article.
Toll-Like Receptor-4 Antagonist (+)-Naloxone Confers Sexually Dimorphic Protection From Inflammation-Induced Fetal Programming in Mice.
Chin PY, Dorian C, Sharkey DJ, Hutchinson MR, Rice KC, Moldenhauer LM, Robertson SA. Chin PY, et al. Endocrinology. 2019 Nov 1;160(11):2646-2662. doi: 10.1210/en.2019-00493. Endocrinology. 2019. PMID: 31504393 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Bentham Science Publishers Ltd.
- Ingenta plc
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?

Affiliations

Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?

Authors

Affiliations

Abstract

Similar articles

Cited by 6 articles

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources